Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.70
+0.45 (1.31%)
Nov 19, 2024, 1:30 PM CST

Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 14.63 billion as of November 21, 2024. Its market cap has increased by 5.18% in one year.

Market Cap
14.63B
Enterprise Value
16.61B
Revenue
5.38B
Ranking
n/a
PE Ratio
20.50
Stock Price
34.70

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 14.63B, an increase of 2,407.07%. That is a compound annual growth rate of 18.97%.

History

DateMarket Cap% Change
Nov 20, 202414.54B-1.10%
Dec 29, 202314.71B-8.20%
Dec 30, 202216.02B128.36%
Dec 30, 20217.02B2.96%
Dec 31, 20206.81B20.87%
Dec 31, 20195.64B7.93%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro
Dec 31, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition